Non-erosive reflux disease - Defining the entity and delineating the management

Digestion

Volumn 78, Issue SUPPL. 1, 2008, Pages 1-5

  Modlin, Irvin M ^a,i   Hunt, Richard H ^c   Malfertheiner, Peter ^d   Moayyedi, Paul ^c   Quigley, Eamon M ^e   Tytgat, Guido N J ^f   Tack, Jan ^g   Holtmann, Gerald ^h   Moss, Steven F ^b  

^a YALE UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY COLLEGE CORK   (Ireland)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h UNIVERSITY OF ADELAIDE   (Australia)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acid suppression; Gastric acid; Gastroesophageal reflux disease; Heartburn

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ANEMIA; CONFERENCE PAPER; DELPHI STUDY; DISEASE SEVERITY; DRUG EFFICACY; DYSPEPSIA; DYSPHAGIA; ENDOSCOPY; ESOPHAGEAL PH MONITORING; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INTESTINE BIOPSY; IRRITABLE COLON; NON EROSIVE REFLUX DISEASE; PATHOGENESIS; PATHOLOGY; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; STOMACH FUNCTION DISORDER; THORAX PAIN; TREATMENT RESPONSE; WEIGHT REDUCTION;

GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HUMANS;

EID: 53349109511     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151248     Document Type: Conference Paper

References (10)

1. Galmiche JP, Clouse RE, Balint A, Cook IJ, Kahrilas PJ, Paterson WG, Smout AJPM: Functional esophageal disorders. Gastroenterology 2006;130:1459-1465.
2. Bernstein S, Laouri M, Hilborne LH, Leape LL, Kahan JP, Park RE, Kamberg CJ, Brook RH: Coronary angiography: a literature review and ratings of appropriateness and necessity. RAND JRA-03, 1992.
3. Labenz J, Nocon M, Lind T, Leodolter A, Jaspersen D, Meyer-Sabellek W, Stolte M, Vieth M, Willich SN, Malfertheiner P: Prospective follow-up data from the ProGERD study suggest that GERD is not a categorical disease. Am J Gastroenterol 2006;101:2457-2462.
4. McColl E: Best practice in symptom assessment: a review. Gut 2004;53(suppl 4):iv49-iv54.
5. Sharma N, Donnellan C, Preston C, Delaney B, Duckett G, Moayyedi P: A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials. Gut 2004;53(suppl 4):iv58-iv65.
6. Armstrong D, Monnikes H, Bardhan KD, Stanghellini V: The construction of a new evaluative GERD questionnaire - methods and state of the art. Digestion 2004;70:71-78.
7. Trimble KC, Pryde A, Heading RC: Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995;37:7-12.
8. Moss SF, Kidd M, Modlin IM: The status of the hiatus: the role of hernia in gastroesophageal reflux disease. J Clin Gastroenterol 2007;41:S144-S153.
9. Johnson LF, Demeester TR: Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974;62:325-332.
10. 2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2006;3:CD002095.